Brigid Reynolds
Advanced Practice Registered Nurse · MedStar Health
Credentials: · · ·
History
- 2024–Present
Research
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Neurology · 2015 · 571 citations
A phase II trial of huperzine A in mild to moderate Alzheimer disease
Neurology · 2011 · 162 citations
Proceedings of the National Academy of Sciences of the United States of America · 2012 · 45 citations
- RT
7 papers
4 papers
- CD
3 papers
3 papers
- AF
2 papers
2 papers
2 papers
2 papers
Grants
- 2025–2028
Life’s End Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study
National Institute on Aging · R01
PI · $4.1M · Medical University of South Carolina
- 2020–2026
LifeâÂÂs End Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial
National Institute on Aging · R01
PI · $15.7M · Medical University of South Carolina
- 2009–2010
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $54.4K · Georgetown University
Clinical trials
- 2024–2026
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Principal investigator · Completed · Phase 2
University of Southern California